| scholarly article | Q13442814 |
| P50 | author | Rodrigo A Panepucci | Q56616469 |
| P2093 | author name string | Dimas Tadeu Covas | |
| Amanda Cristina Corveloni | |||
| Vitor Marcel Faça | |||
| Josiane Lilian Dos Santos Schiavinato | |||
| Danuta Sastre | |||
| Felipe Canto de Souza | |||
| Carolina Hassib Thomé | |||
| Ildercilio Mota de Souza Lima | |||
| João Baiochi | |||
| P2860 | cites work | Hypermethylation of BEND5 contributes to cell proliferation and is a prognostic marker of colorectal cancer | Q47645638 |
| In vitro transfection of anti-tumor miR-101 induces BIM, a pro-apoptotic protein, expression in acute myeloid leukemia (AML). | Q49642332 | ||
| MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway | Q49824205 | ||
| The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer | Q49914541 | ||
| Mechanism and Method for Generating Tumor-Free iPS Cells Using Intronic MicroRNA miR-302 Induction | Q50045356 | ||
| MicroRNA-101 inhibits proliferation of pulmonary microvascular endothelial cells in a rat model of hepatopulmonary syndrome by targeting the JAK2/STAT3 signaling pathway. | Q50920336 | ||
| Multimodal tumor suppression by miR-302 cluster in melanoma and colon cancer. | Q51066776 | ||
| Mcl-1 Degradation Is Required for Targeted Therapeutics to Eradicate Colon Cancer Cells. | Q51136478 | ||
| Cell Cycle Regulation of Stem Cells by MicroRNAs. | Q52726443 | ||
| MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR. | Q52747351 | ||
| Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. | Q53416418 | ||
| MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells. | Q53468816 | ||
| miR-101 acts as a tumor suppressor by targeting Kruppel-like factor 6 in glioblastoma stem cells. | Q54321491 | ||
| Nemo-like kinase (NLK) primes colorectal cancer progression by releasing the E2F1 complex from HDAC1. | Q54978102 | ||
| Low Serum Levels of miR-101 Are Associated with Poor Prognosis of Colorectal Cancer Patients After Curative Resection | Q57808727 | ||
| MicroRNA-23a promotes colorectal cancer cell survival by targeting PDK4 | Q57812276 | ||
| Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis | Q82783887 | ||
| Cell Line Models of Molecular Subtypes of Colorectal Cancer | Q88197992 | ||
| Wnt signaling pathway upregulates DNMT1 to trigger NHERF1 promoter hypermethylation in colon cancer | Q89100002 | ||
| MiR-363-3p suppresses tumor growth and metastasis of colorectal cancer via targeting SphK2 | Q90317777 | ||
| Bioconductor: open software development for computational biology and bioinformatics | Q21194861 | ||
| Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states | Q21260380 | ||
| NIH Image to ImageJ: 25 years of image analysis | Q23319322 | ||
| MCL-1ES, a novel variant of MCL-1, associates with MCL-1L and induces mitochondrial cell death | Q24329218 | ||
| KEGG: kyoto encyclopedia of genes and genomes | Q24515297 | ||
| MicroRNA maturation: stepwise processing and subcellular localization | Q24534359 | ||
| Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 | ||
| MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer | Q24643430 | ||
| MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression | Q24643470 | ||
| Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer | Q24646844 | ||
| The Three Paralogous MicroRNA Clusters in Development and Disease, miR-17-92, miR-106a-363, and miR-106b-25 | Q26748969 | ||
| The insights of Let-7 miRNAs in oncogenesis and stem cell potency | Q26751493 | ||
| The miR-302/367 cluster: a comprehensive update on its evolution and functions | Q26775301 | ||
| MicroRNAs in colorectal cancer: from diagnosis to targeted therapy | Q26825307 | ||
| Mammalian microRNAs predominantly act to decrease target mRNA levels | Q27860535 | ||
| Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial-mesenchymal transition | Q28114963 | ||
| miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. | Q45944020 | ||
| miR-27a-3p targeting RXRα promotes colorectal cancer progression by activating Wnt/β-catenin pathway | Q47168497 | ||
| Cancer statistics, 2018. | Q47191906 | ||
| Promoter hypermethylation inactivate tumour suppressor FAM134B and is associated with poor prognosis in colorectal cancer | Q47214865 | ||
| Reduced accumulation of specific microRNAs in colorectal neoplasia | Q28211976 | ||
| Sustained proliferation in cancer: Mechanisms and novel therapeutic targets | Q28396388 | ||
| IL-6 regulates Mcl-1L expression through the JAK/PI3K/Akt/CREB signaling pathway in hepatocytes: implication of an anti-apoptotic role during liver regeneration | Q28534312 | ||
| The landscape of somatic copy-number alteration across human cancers | Q29547648 | ||
| Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency | Q29616797 | ||
| limma powers differential expression analyses for RNA-sequencing and microarray studies | Q29617988 | ||
| RNA silencing of Mcl-1 enhances ABT-737-mediated apoptosis in melanoma: role for a caspase-8-dependent pathway | Q33494047 | ||
| EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics | Q33566687 | ||
| Serum MicroRNA profile in patients with colon adenomas or cancer | Q33587284 | ||
| Variability in the incidence of miRNAs and genes in fragile sites and the role of repeats and CpG islands in the distribution of genetic material | Q33612207 | ||
| Identification of miR-101-3p targets and functional features based on bioinformatics, meta-analysis and experimental verification in hepatocellular carcinoma | Q33733091 | ||
| Upregulation of miR-101 enhances the cytotoxic effect of anticancer drugs through inhibition of colon cancer cell proliferation | Q33858033 | ||
| EZH2 depletion blocks the proliferation of colon cancer cells | Q33963796 | ||
| Tumor suppressor microRNA-27a in colorectal carcinogenesis and progression by targeting SGPP1 and Smad2 | Q34105277 | ||
| MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells | Q34227586 | ||
| MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1. | Q34446981 | ||
| MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer | Q34529938 | ||
| Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. | Q34783833 | ||
| Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer | Q34793233 | ||
| Diagnostic and prognostic microRNAs in stage II colon cancer. | Q34803800 | ||
| STAT3 is necessary for proliferation and survival in colon cancer-initiating cells | Q34971936 | ||
| Characterization of microRNAs involved in embryonic stem cell states | Q35082773 | ||
| Circulating exosomal microRNAs as biomarkers of colon cancer. | Q35140085 | ||
| Genome-scale analysis of aberrant DNA methylation in colorectal cancer | Q35694387 | ||
| Restoration of miR-101 suppresses lung tumorigenesis through inhibition of DNMT3a-dependent DNA methylation | Q35966279 | ||
| Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma | Q35987115 | ||
| EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells | Q36212878 | ||
| Mcl-1 involvement in mitochondrial dynamics is associated with apoptotic cell death | Q36412965 | ||
| MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? | Q36438314 | ||
| Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer | Q36857592 | ||
| Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state | Q36909649 | ||
| OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer | Q37059796 | ||
| Site-specific associations between miRNA expression and survival in colorectal cancer cases | Q37645004 | ||
| Polycomb proteins control proliferation and transformation independently of cell cycle checkpoints by regulating DNA replication | Q37718268 | ||
| A panel of microRNA signature in serum for colorectal cancer diagnosis | Q37725573 | ||
| Mcl-1; the molecular regulation of protein function | Q37764383 | ||
| From microRNAs to targets: pathway discovery in cell fate transitions | Q37884235 | ||
| MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment | Q38147153 | ||
| STAT3 Target Genes Relevant to Human Cancers | Q38205362 | ||
| DNA Methylation and Colorectal Cancer | Q38314840 | ||
| Towards a molecular understanding of microRNA-mediated gene silencing | Q38528410 | ||
| Upregulation of MicroRNA 18b Contributes to the Development of Colorectal Cancer by Inhibiting CDKN2B. | Q38636195 | ||
| Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies | Q38690672 | ||
| EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line. | Q38696296 | ||
| MicroRNA-101 inhibits proliferation, migration and invasion in osteosarcoma cells by targeting ROCK1. | Q38719379 | ||
| Methyl jasmonate induces the apoptosis of human colorectal cancer cells via downregulation of EZH2 expression by microRNA‑101. | Q38725057 | ||
| MicroRNA-101 sensitizes hepatocellular carcinoma cells to doxorubicin-induced apoptosis via targeting Mcl-1. | Q38807863 | ||
| MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations | Q38813857 | ||
| Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells | Q38848185 | ||
| Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways | Q38851330 | ||
| MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase | Q38943961 | ||
| Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer | Q39001975 | ||
| MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer | Q39030067 | ||
| MiR-101 functions as a tumor suppressor by directly targeting nemo-like kinase in liver cancer | Q39067133 | ||
| miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9. | Q39188790 | ||
| Prognostic role of microRNAs in human gastrointestinal cancer: A systematic review and meta-analysis | Q39237748 | ||
| Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis | Q39261789 | ||
| Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells | Q39289136 | ||
| MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancers | Q39392750 | ||
| Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma. | Q39434683 | ||
| MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. | Q39897268 | ||
| A STAT3 Gene Expression Signature in Gliomas is Associated with a Poor Prognosis | Q40055297 | ||
| Characterization of HCT116 human colon cancer cells in an orthotopic model | Q40062205 | ||
| Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth | Q40394995 | ||
| Preliminary evidence of different selection pressures on cancer cells as compared to normal tissues | Q41682086 | ||
| Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma | Q41921103 | ||
| The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. | Q42064781 | ||
| Linking Pluripotency Reprogramming and Cancer | Q42247704 | ||
| Prognostic significance of microRNA-101 in solid tumor: A meta-analysis | Q42337047 | ||
| The prognostic value of decreased miR-101 in various cancers: a meta-analysis of 12 studies | Q42339145 | ||
| Clinical significance of miR-22 expression in patients with colorectal cancer | Q44031349 | ||
| microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers | Q44586065 | ||
| Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation | Q44926251 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| limma | Q112236343 | ||
| P433 | issue | 1 | |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 1239 | |
| P577 | publication date | 2019-12-21 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Focused screening reveals functional effects of microRNAs differentially expressed in colorectal cancer | |
| P478 | volume | 19 |
| Q98291418 | Fibroblast-Derived Extracellular Vesicles Induce Colorectal Cancer Progression by Transmitting Amphiregulin |
| Q102206178 | LncRNA CASC2 targets CAV1 by competitively binding with microRNA-194-5p to inhibit neonatal lung injury |
| Q94452971 | MicroRNA-584 Impairs Cellular Proliferation and Sensitizes Osteosarcoma Cells to Cisplatin and Taxanes by Targeting CCN2 |
Search more.